சிவப்பு டியூக் அதிர்ச்சி நிறுவனம் இல் நினைவகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First patient enrolled in Phase II clinical trial of stem cell therapy for traumatic injuries
The first patient has enrolled in a Phase II clinical trial evaluating a stem cell therapy for the potential early treatment of traumatic injuries and their subsequent complications at The University of Texas Health Science Center at Houston (UTHealth).
The MATRICS-1 (MultiStem
® Administration for Trauma Related Inflammation and Complications) study is being conducted at Memorial Hermann-Texas Medical Center.
According to the Centers for Disease Control (CDC), trauma is the leading cause of death for individuals under the age of 45 and the third leading cause of death in the U.S., accounting for approximately 180,000 fatalities each year. It is also a leading cause of serious disability, especially among young people and members of the military that suffer trauma. ....

Charless Cox Jr , Emily Henderson , Red Duke Trauma Institute At Memorial , Us Army Medical Research , Administration For Trauma Related Inflammation , Texas Medical Center , Centers For Disease Control , Memorial Hermann Foundation , Mcgovern Medical School , Technology Enterprise Consortium , Texas Health Science Center , Trauma Related Inflammation , Memorial Hermann Texas Medical , Disease Control , Cynthia Mitchell Distinguished Chair , Pediatric Surgery , Red Duke Trauma Institute , Faculty Member , Graduate School , Medical Technology Enterprise Consortium , Mcgovern Medical , Medical Research , எமிலி ஹென்டர்சன் , சிவப்பு டியூக் அதிர்ச்சி நிறுவனம் இல் நினைவகம் , எங்களுக்கு இராணுவம் மருத்துவ ஆராய்ச்சி , டெக்சாஸ் மருத்துவ மையம் ,